about
Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activityTreatment of Cushing disease: overview and recent findingsMedical treatment of Cushing's disease: Overview and recent findings.Resistant hypertension workup and approach to treatmentIncreased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencySubclinical Atherosclerosis in Patients with Cushing Syndrome: Evaluation with Carotid Intima-Media Thickness and Ankle-Brachial Index.Association between the metabolic syndrome and serum cortisol in overweight Latino youth.Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Quality of life and other outcomes in children treated for Cushing syndrome.Blood pressure in pediatric patients with Cushing syndrome.Pasireotide for the treatment of Cushing's disease.Pros and cons of screening for occult Cushing syndrome.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Mifepristone: is there a place in the treatment of Cushing's disease?Glucocorticoids and the regulation of growth hormone secretion.Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues.Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Relations between recurrent trauma exposure and recent life stress and salivary cortisol among children.A venous thromboembolism risk assessment model for patients with Cushing's syndrome.Intracerebral hemorrhage revealing a Cushing's disease.Patients with the metabolic syndrome and a disturbed cortisol balance display more microalbuminuria.Assessment of left ventricular functions by tissue Doppler echocardiography in patients with Cushing's disease.Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome.Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL.Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
P2860
Q24613705-CD839D41-645C-4D32-AAD9-DA885F6014C8Q24626819-2B0B1533-2078-45CD-B71A-7B9B2B149A30Q33735039-B750AA30-7698-4DCD-BE20-758ED1D4F30DQ34460704-C5C2D5B4-9023-4B11-9FE9-E60C91CC2FB7Q35916502-669A0E24-D2AB-45C3-A541-05E74662138FQ36489131-FBAD56C6-4C91-4889-A5CF-D3CD7AD751BEQ36536802-CD6EF0CD-425D-46B0-BA43-FB7DB32C1C51Q36795530-F361CE5D-C56B-4494-A4CA-B69A9C492191Q36981968-7C342D3E-EB49-46F6-9E67-76D10F061C94Q37212316-6098C45A-2EEA-4927-94CF-302F16786B3EQ37763714-36DA6ED0-19FE-4F65-AA80-0E35B0A48255Q37855520-69EF69AA-A63E-4D4D-A584-D344EB713D32Q38015162-55E61DBF-921D-44F5-AAD9-CB20161555C8Q38063404-D96DFFD8-0AE5-4EDD-AF95-6B84329862E7Q38079133-12F07426-C0A6-4AB5-BDA5-CFE67A66DDE8Q38207093-286F1CBB-D06E-4441-8452-66CA878AB783Q38656281-6A9E94E7-407D-4EA4-839E-66A3B187F9E5Q38683309-ED6B71B5-BEA8-409A-9203-794A70292327Q39829840-EE7FDFE1-EC04-4309-A86C-9C7A1789BBABQ40795123-EAEF32C0-CF6C-4B14-A832-134063170683Q43202406-2119F7A9-4E19-4FB5-BADD-D14BB9296490Q45083212-E2C518B3-E171-4F00-A010-FEF25B28AF89Q45960393-0556F61A-3D6A-41A3-BDF4-B864EB2E0B45Q46535201-B2036281-7DA0-4832-AB81-209134415AB0Q47364550-8BD68457-6EAC-4A78-9B94-38712A0F99A7Q59043920-B16BC7C6-4749-4C77-AFF7-92BDF6677E84
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cardiovascular risk in Cushing's syndrome.
@ast
Cardiovascular risk in Cushing's syndrome.
@en
type
label
Cardiovascular risk in Cushing's syndrome.
@ast
Cardiovascular risk in Cushing's syndrome.
@en
prefLabel
Cardiovascular risk in Cushing's syndrome.
@ast
Cardiovascular risk in Cushing's syndrome.
@en
P2093
P1433
P1476
Cardiovascular risk in Cushing's syndrome.
@en
P2093
Barbara Polenta
Giorgio Arnaldi
Marco Boscaro
Tatiana Mancini
P2888
P304
P356
10.1007/S11102-005-1172-7
P577
2004-01-01T00:00:00Z